Efficacy of stereotactic body radiotherapy and response prediction using artificial intelligence in oligometastatic gynaecologic cancer-Reference-Cited by-同舟云学术

Efficacy of stereotactic body radiotherapy and response prediction using artificial intelligence in oligometastatic gynaecologic cancer

Published:2024-05 Issue: Volume:184 Page:16-23
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Macchia Gabriella,Cilla Savino,Pezzulla Donato,Campitelli Maura,Laliscia Concetta,Lazzari Roberta,Draghini Lorena,Fodor Andrei,D'Agostino Giuseppe R.,Russo Donatella,Balcet Vittoria,Ferioli Martina,Vicenzi Lisa,Raguso Arcangela,Di Cataldo Vanessa,Perrucci Elisabetta,Borghesi Simona,Ippolito Edy,Gentile Piercarlo,De Sanctis Vitaliana,Titone Francesca,Delle Curti Clelia Teresa,Huscher Alessandra,Gambacorta Maria Antonietta,Ferrandina Gabriella,Morganti Alessio G.,Deodato Francesco

Publisher

Elsevier BV

Reference30 articles.

1. Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation;Guckenberger;Lancet Oncol.,2020

2. Role of stereotactic body radiotherapy in gynecologic radiation oncology;Shenker;Int. J. Gynecol. Cancer,2022

3. Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study;Gomez;Lancet Oncol.,2016

4. Consolidative radiotherapy for limited metastatic non-small-cell lung cancer: a phase 2 randomized clinical trial;Iyengar;JAMA Oncol.,2018

5. Outcomes of observation vs stereotactic ablative radiation for Oligometastatic prostate Cancer: the ORIOLE phase 2 randomized clinical trial;Phillips;JAMA Oncol.,2020

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. STEREOTACTIC BODY RADIOTHERAPY FOR OLIGOPROGRESSIVE OVARIAN CANCER PATIENTS TREATED DURING PARP INHIBITOR MAINTENANCE: EFFICACY AND ADVERSE EVENTS FROM THE EPIMETHEO RETROSPECTIVE STUDY;International Journal of Radiation Oncology*Biology*Physics;2024-09